Sign In to Follow Application
View All Documents & Correspondence

Method For Detection Of Anti Rituximab Antibodies

Abstract: This invention is related to a method for detecting anti-rituximab antibodies in a RF positive plasma samples, wherein the method mitigated the interference of RF to a significant level using biotinylated F(ab)2 fragments of rituximab as detecting agent. The method also used a pre-treatment step with acidic buffer containing glycine, prior to subjecting the samples for detection of anti-rituximab antibodies.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
11 February 2014
Publication Number
36/2016
Publication Type
INA
Invention Field
BIO-CHEMISTRY
Status
Email
srinivasvr@drreddys.com
Parent Application
Patent Number
Legal Status
Grant Date
2021-03-02
Renewal Date

Applicants

Dr. Reddy’s Laboratories Limited
Intellectual Property Management Biologics development Center Dr. Reddy’s Laboratories Limited Survey Nos. 47, Bachupalli, Qutubullapur, RR District, AP, India

Inventors

1. Lella Ravi kumar
Lellavari Street, Jandrapet (P.O) ChiralaMandal Prakasam (Dist.)-523165 Andhra Pradesh
2. Moram Narendra Babu
Flat no:402, Sidhartha residency Plot no: 130 A&B, HUDA Colony, Phase-II, Chandanagar, Hyderabad-500050 Andhra Pradesh.
3. Sridevi Khambhampaty
7A, Vertex Lakeview Nizampet Road Hyderabad – 500090 Andhra Pradesh.

Specification

SOFT COPY ATTACHED IN PDF

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 644-CHE-2014-US(14)-HearingNotice-(HearingDate-19-02-2021).pdf 2021-10-17
1 Prov. Form 2.pdf 2014-02-12
2 644-CHE-2014-IntimationOfGrant02-03-2021.pdf 2021-03-02
2 FORM 3.pdf 2014-02-12
3 FORM 5.pdf 2015-03-12
3 644-CHE-2014-PatentCertificate02-03-2021.pdf 2021-03-02
4 FORM 2.pdf 2015-03-12
4 644-CHE-2014-Written submissions and relevant documents [25-02-2021(online)].pdf 2021-02-25
5 644-CHE-2014-CLAIMS [25-11-2020(online)].pdf 2020-11-25
5 644-CHE-2014 FORM-3 27-03-2015.pdf 2015-03-27
6 644-CHE-2014-CORRESPONDENCE [25-11-2020(online)].pdf 2020-11-25
6 644-CHE-2014 CORRESPONDENCE OTHERS 27-03-2015.pdf 2015-03-27
7 644-CHE-2014-FORM 18 [06-02-2018(online)].pdf 2018-02-06
7 644-CHE-2014-DRAWING [25-11-2020(online)].pdf 2020-11-25
8 644-CHE-2014-FER.pdf 2020-05-27
8 644-CHE-2014-FER_SER_REPLY [25-11-2020(online)].pdf 2020-11-25
9 644-CHE-2014-OTHERS [25-11-2020(online)].pdf 2020-11-25
10 644-CHE-2014-FER_SER_REPLY [25-11-2020(online)].pdf 2020-11-25
10 644-CHE-2014-FER.pdf 2020-05-27
11 644-CHE-2014-FORM 18 [06-02-2018(online)].pdf 2018-02-06
11 644-CHE-2014-DRAWING [25-11-2020(online)].pdf 2020-11-25
12 644-CHE-2014-CORRESPONDENCE [25-11-2020(online)].pdf 2020-11-25
12 644-CHE-2014 CORRESPONDENCE OTHERS 27-03-2015.pdf 2015-03-27
13 644-CHE-2014-CLAIMS [25-11-2020(online)].pdf 2020-11-25
13 644-CHE-2014 FORM-3 27-03-2015.pdf 2015-03-27
14 FORM 2.pdf 2015-03-12
14 644-CHE-2014-Written submissions and relevant documents [25-02-2021(online)].pdf 2021-02-25
15 FORM 5.pdf 2015-03-12
15 644-CHE-2014-PatentCertificate02-03-2021.pdf 2021-03-02
16 FORM 3.pdf 2014-02-12
16 644-CHE-2014-IntimationOfGrant02-03-2021.pdf 2021-03-02
17 Prov. Form 2.pdf 2014-02-12
17 644-CHE-2014-US(14)-HearingNotice-(HearingDate-19-02-2021).pdf 2021-10-17

Search Strategy

1 2020-03-1110-58-09E_11-03-2020.pdf

ERegister / Renewals

3rd: 25 May 2021

From 11/02/2016 - To 11/02/2017

4th: 25 May 2021

From 11/02/2017 - To 11/02/2018

5th: 25 May 2021

From 11/02/2018 - To 11/02/2019

6th: 25 May 2021

From 11/02/2019 - To 11/02/2020

7th: 25 May 2021

From 11/02/2020 - To 11/02/2021

8th: 25 May 2021

From 11/02/2021 - To 11/02/2022

9th: 25 May 2021

From 11/02/2022 - To 11/02/2023

10th: 11 Feb 2023

From 11/02/2023 - To 11/02/2024